Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.53 |
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31235967 | 0.91 | GPR119 (0.56) | NR1H2GPR119HRH3KMT2ANAMPT | |
| SCHEMBL31236000 | 0.91 | GPR119 (0.58) | NR1H2GPR119HRH3ESR2IDO1 | |
| SCHEMBL25335823 | 0.86 | GPR119 (0.48) | NR1H2GPR119HRH3KMT2AESR2 | |
| SCHEMBL19030363 | 0.86 | GPR119 (0.48) | GPR119HRH3KMT2AESR2HDAC1 | |
| SCHEMBL23110805 | 0.86 | GPR119 (0.48) | GPR119HRH3KMT2AESR2 | |
| SCHEMBL20602904 | 0.86 | NR1H2 (0.50) | NR1H2GPR119HRH3KMT2AESR2 | |
| SCHEMBL30109297 | 0.86 | NR1H2 (0.50) | NR1H2GPR119HRH3KMT2AESR2 | |
| SCHEMBL731546 | 0.84 | KMT2A (0.58) | NR1H2GPR119HRH3KMT2AHDAC1 | |
| SCHEMBL17848653 | 0.83 | GPR119 (0.54) | GPR119HRH3IDO1 | |
| SCHEMBL31094899 | 0.83 | GPR119 (0.54) | GPR119HRH3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722219-A1 | CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION | Gan & Lee Pharmaceuticals Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024240268-A1 | CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION | 甘李药业股份有限公司 | 2024-11-28 | — | — | WO | disclosed |